The federal agency known as the FDA, or the Food and Drug Administration, was born over 100 years ago—at the turn of the industrial revolution, in a time of enormous upheaval and change, and rapidly emerging technology. The same could be said to be just as true today. This wide-ranging conversation between Principal Commissioner of the FDA Amy Abernethy and Vijay Pande, GP on the Bio Fund at a16z, discusses how the agency is evolving to keep pace with the scientific breakthroughs like CRISPR and AI, while staying true to its core mission of assessing safety and effectiveness for consumers in the world of food and medicine.
Podden och tillhörande omslagsbild på den här sidan tillhör Andreessen Horowitz. Innehållet i podden är skapat av Andreessen Horowitz och inte av, eller tillsammans med, Poddtoppen.